Tables index

From

Orlistat and Hydroxycitrate Ameliorate Colon Cancer in Rats: The Impact of Inflammatory Mediators

Hesham Fathy Hassan Hassan, Ahmed Mohamed Mansour, El-Sayed Mohamed El-Sayed

Journal of Food and Nutrition Research. 2022, 10(1), 41-49 doi:10.12691/jfnr-10-1-6
  • Table 1. Effect of treatment with orlistat or hydroxycitrate (HCA) on growth rate, % of mortality, incidence of tumor and % of ACF incidence of DMH and/or HFD-treated rats
  • Table 2. Effect of treatment with orlistat or hydroxycitrate (HCA) on serum tumor marker levels of CEA and CA19-9 of DMH and/or HFD-treated rats
  • Table 3. Effect of treatment with orlistat or hydroxycitrate (HCA) on caspase-3 content as an apoptotic marker in the colonic tissues of DMH and/or HFD-treated rats
  • Table 4. Effect of treatment with orlistat or hydroxycitrate (HCA) on inflammatory markers (IL-6, TNF-α and NF-κB) content in the colonic tissues of DMH DMH and/or HFD-treated rats
  • Table 5. Effect of treatment with orlistat or hydroxycitrate (HCA) on the oxidative stress parameters in the colonic tissues of DMH and/or HFD-treated rats
  • Table 6. Effect of treatment with orlistat and/ or hydroxycitrate (HCA) on histopathological findings of colonic tissues of DMH and/or HFD-treated rats